Skip to main content
Clinical Trials/NCT04226820
NCT04226820RecruitingNot Applicable

Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus

University Ghent1 site in 1 country125 target enrollmentStarted: February 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
125
Locations
1
Primary Endpoint
Near-infrared spectroscopy during exercise

Study Overview

Brief Summary

Oxygen is required for an optimal muscle function. In patients with diabetes mellitus, hyperglycemia can cause vascular complications. The endothelium (inter layer of the blood vessels) can be damaged leading to a reduced oxygen flow towards the muscle cells. Besides, it is possible that mitochondrial dysfunction is occuring leading to reduced extraction of oxygen.

Both conditions will lead to a reduced flow of oxygen towards the muscle and this can have impact on the production of energy necessary for optimal functioning.

In this study, the investigators will examine the functionality of the blood vessels (1) and the uptake of oxygen into the muscles (2) in patients with diabetes mellitus type 1 and type 2 (with and without vascular complications) compared to healthy persons.

Detailed Description

The investigators plan to recruit in total 125 participants who will be divided into 3 main groups: (I) diabetes mellitus type 1 (with (a) or without (b) vascular complications), (II) diabetes mellitus type 2 (with (a) or without (b) vascular complications), and (III) healthy persons. Diabetes mellitus will be defined by the guidelines of the American Diabetes Association (ADA).

The examinations for this study consist of a blood pressure assessment, Flow Mediated Dilatation (FMD)-measurement, and a handgrip exercise test. The protocol will take approximately 2 hours.

The investigator who performs the FMD-test followed a course and passed thorough evaluation.

The blood pressure assessment will be continuously for 20 minutes to avoid large bias.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Masking Description

There is no masking because the participant knows his diagnosis. Besides, the investigator checks the blood sugar at different times during the examinations, so also the investigator is not blinded. In this study, blinding would have no additional value.

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •men and women
  • •age 18-85 years old
  • •diabetes mellitus type 1 or type 2 (with or without vascular complications, healthy participants

Exclusion Criteria

  • •other types of diabetes mellitus than type 1 or type 2
  • •alcohol abuse
  • •active cancer
  • •pregnancy

Arms & Interventions

participant

Experimental

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Intervention: examination: blood pressure assessment (Other)

participant

Experimental

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Intervention: examination: Flow Mediated Dilatation (FMD)-test (Other)

participant

Experimental

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Intervention: examination: handgrip exercise test with Near infrared spectroscopy (NIRS)-monitoring (Other)

participant

Experimental

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Intervention: examination: measurement of glucose by a finger prick (Other)

Outcomes

Primary Outcomes

Near-infrared spectroscopy during exercise

Time Frame: 30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)

analysis of changes in oxygenated blood during exercise

Flow Mediated Dilatation (FMD)-test

Time Frame: 20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)

flow mediated dilatation test

exercise test wilt hand held dynamometer

Time Frame: 30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)

analysis of strength and exercise capacity

Secondary Outcomes

  • Blood pressure analysis(20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials